Variant report
Variant | esv3471789 |
---|---|
Chromosome Location | chr6:34698999-34702347 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:34698371..34700265-chr6:34702057..34704593,2 | K562 | blood: | |
2 | chr6:34696691..34699544-chr6:34703628..34706154,2 | K562 | blood: | |
3 | chr6:34698371..34700265-chr6:34702057..34704593,2 | K562 | blood: | |
4 | chr6:34694281..34696402-chr6:34696757..34699128,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533592436 | chr6:34699031-34699032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2764210 | chr6:34699049-34699050 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs200852018 | chr6:34699065-34699066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188040736 | chr6:34699072-34699073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2814956 | chr6:34699109-34699110 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs556161909 | chr6:34699148-34699149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577914067 | chr6:34699161-34699162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181213665 | chr6:34699165-34699166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558591780 | chr6:34699185-34699186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138612688 | chr6:34699186-34699187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572168893 | chr6:34699207-34699208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540698044 | chr6:34699217-34699218 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557527311 | chr6:34699218-34699219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185303986 | chr6:34699236-34699237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371051876 | chr6:34699269-34699270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141146476 | chr6:34699287-34699288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191384238 | chr6:34699293-34699294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150810211 | chr6:34699319-34699320 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35369977 | chr6:34699341-34699342 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs551793528 | chr6:34699360-34699361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567023551 | chr6:34699369-34699370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527892748 | chr6:34699375-34699376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533719242 | chr6:34699397-34699398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183623926 | chr6:34699424-34699425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567049373 | chr6:34699427-34699428 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115206813 | chr6:34699473-34699474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186876345 | chr6:34699492-34699493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192065752 | chr6:34699517-34699518 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs34810186 | chr6:34699600-34699601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538879249 | chr6:34699645-34699646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533512251 | chr6:34699662-34699663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553797610 | chr6:34699703-34699704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572253868 | chr6:34699832-34699833 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183909295 | chr6:34699915-34699916 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369919673 | chr6:34699922-34699923 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112056842 | chr6:34699923-34699924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543958706 | chr6:34699928-34699929 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551757400 | chr6:34700004-34700005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555893674 | chr6:34700052-34700053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574223985 | chr6:34700239-34700240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186866736 | chr6:34700316-34700317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542501896 | chr6:34700351-34700352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199907662 | chr6:34700357-34700358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533196794 | chr6:34700367-34700368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545651109 | chr6:34700447-34700448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560658514 | chr6:34700469-34700470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562488575 | chr6:34700509-34700510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369259212 | chr6:34700523-34700524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149519162 | chr6:34700582-34700583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575980192 | chr6:34700638-34700639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:34696000-34699000 | Weak transcription | K562 | blood |
2 | chr6:34696400-34699400 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr6:34696400-34700600 | Enhancers | HepG2 | liver |
4 | chr6:34697200-34699200 | Enhancers | Fetal Muscle Trunk | muscle |
5 | chr6:34698000-34714000 | Weak transcription | Esophagus | oesophagus |
6 | chr6:34698400-34699000 | Weak transcription | Stomach Mucosa | stomach |
7 | chr6:34699000-34699400 | Enhancers | K562 | blood |
8 | chr6:34699000-34699800 | Enhancers | Stomach Mucosa | stomach |
9 | chr6:34699200-34700000 | Enhancers | Liver | Liver |
10 | chr6:34699400-34707000 | Weak transcription | K562 | blood |
11 | chr6:34699800-34712200 | Weak transcription | Stomach Mucosa | stomach |
12 | chr6:34700600-34703000 | Weak transcription | HepG2 | liver |